caselaw.findlaw.com/us-7th-circuit/1545486.html

NAIK v. BOEHRINGER INGELHEIM PHARMACEUTICALS INCORPORATED ... was fired by his employer, Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI), ... 621 et seq., and Title VII of the Civil Rights Act of 1964, 42 U.S.C. §§ 2000e et seq. ... At a sales meeting in early 2005, Somers informed all district managers that ...

law.justia.com/cases/federal/district-courts/west-virginia/wvsdce/3:2015cv06424/189053/118

Knight et al v. Boehringer Ingelheim Pharmaceuticals, Inc., No. 3:2015cv06424 - Document 118 (S.D.W. Va. 2018) case opinion from the Southern District of ...

law.justia.com/cases/federal/district-courts/new-jersey/njdce/3:2015cv05982/323095/388

Dec 7, 2016 ... BOEHRINGER INGELHEIM PHARMACEUTICALS INC. et al v. HEC PHARM CO. , LTD. et al, No. 3:2015cv05982 - Document 388 (D.N.J. 2016) ...

www.ncbi.nlm.nih.gov/pmc/articles/PMC4147718

Aug 28, 2014 ... Kenneth R. Watterson,1 Brian D. Hudson,1 Trond Ulven,2 and ..... Sanofi and Boehringer-Ingelheim are also reported to have FFA1 .... Ltd, IRM LLC USA, Metabolex, Inc., Kindex Therapeutics, and Pharma Frontier Co., Ltd have all .... Ferdaoussi M, Bergeron V, Zarrouki B, Kolic J, Cantley J, Fielitz J, et al.

www.ncbi.nlm.nih.gov/pmc/articles/PMC3000806

Dec 10, 2010 ... 5 advanced NCEs from the project [18] (BI1-BI5, see Roth et al.) .... All previously selected genes (TGF-β stim. vs. unstimulated cells, Fig. ...... KG DM, LM and LG are employees of Boehringer Ingelheim Pharmaceuticals Inc. This does not alter the authors' adherence .... Chico LK, Van Eldik LJ, Watterson DM.

journals.plos.org/plosone/article?id=10.1371/journal.pone.0132810

Jul 30, 2015 ... Boehringer Ingelheim Pharma GmbH & Co. ... KG, a company developing drugs for the treatment of chronic obstructive pulmonary disease (COPD). ...... Waisman D, Brod V, Wolff R, Sanop E, Chernin M, Weintraub Z, et al. Effects of ..... Rossi JL, Velentza AV, Steinhorn DM, Watterson DM, Wainwright MS.

pharmrev.aspetjournals.org/content/pharmrev/69/3/316.full.pdf

School of Pharmacy, University of Otago, Dunedin, New Zealand. Abstract. .... V. Antibodies . .... et al., 1993) and is expressed predominantly in immune ...... Birke F and Stiasni M (1989) inventors, Boehringer Ingelheim Kg, assignee. .... Christiansen E, Watterson KR, Stocker CJ, Sokol E, Jenkins L, Simon K, Grundmann.

aac.asm.org/content/aac/52/6/1957.full.pdf

All coated prostheses reduced bacterial growth drastically over 24 h, even below ... drug binding is the incorporation of drugs into biodegradable polymer ... (a) PDLLA. Resomer R203H, purchased from Boehringer Ingelheim (In- .... by ITEM GmbH—The Biotooling Company (Garching, Germany) and were ... MATL ET AL.

www.lungcancerjournal.info/article/S0169-5002(16)30397-X/fulltext

Jul 5, 2016 ... LDK378 (ceritinib, Zykadia; Novartis Pharmaceuticals, Basel, ..... funding from AstraZeneca/MedImmune and Boehringer Ingelheim. ... that was sponsored by Astellas Pharma Inc. The patient described in this report ... D.R., Hornick, J.L., Dal Cin, P., Antonescu, C.R., Jhanwar, S.C. et al. .... Gounant, V. et al.